Table 2.
Trio | % 10X reads | % 20X reads | Number of variants | LoF/Missense | Compound heterozygous | Homozygous variants | De novo variants |
---|---|---|---|---|---|---|---|
Proband 1 | 96.55 | 91.72 | 116,189 | 858 | 33 (14 genes) | 3 | 6 |
Mother | 96.86 | 93.01 | 117,082 | ||||
Father | 97.37 | 91.84 | 115,855 | ||||
Proband 2 | 96.78 | 92.52 | 123,862 | 1005 | 48 (20 genes) | 9 | 12 |
Mother | 97.21 | 91.60 | 123,725 | ||||
Father | 98.37 | 95.71 | 123,111 | ||||
Proband 3 | 96.34 | 86.23 | 121,215 | 847 | 54 (23 genes) | 16 | 8 |
Mother | 97.65 | 93.36 | 121,163 | ||||
Father | 97.45 | 92.79 | 122,161 | ||||
Proband 4 | 97.37 | 93.12 | 125,668 | 885 | 70 (23 genes) | 5 | 3 |
Mother | 97.24 | 93.95 | 126,700 | ||||
Father | 97.26 | 92.61 | 124,454 |
% 10X reads, percentage of nucleotide positions covered by at least 10 reads after application of filtering and fragments de-duplication procedures; % 20X reads, percentage of nucleotide positions covered by at least 20 reads after application of filtering and fragments de-duplication procedures; LoF, Loss of Function.